During the past decade, Centre Hospitalier Marc Jacquet conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 1 clinical trials were completed, i.e. on average, 4.3% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 1 clinical trials were completed. i.e. 7.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier Marc Jacquet" #1 sponsor was "Assistance Publique - Hôpitaux de Paris" with 3 trials, followed by "Centre Hospitalier Departemental Vendee" with 3 trials sponsored, "The Lymphoma Academic Research Organisation" with 3 trials sponsored, "ANRS, Emerging Infectious Diseases" with 2 trials sponsored and "Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer" with 2 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier Marc Jacquet" #1 collaborator was "University Hospital, Tours" with 3 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 2 trials as a collaborator, "Ministry of Health, France" with 2 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator and "CHU de Nancy" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier Marc Jacquet" are "Shock" (3 trials), "Acute Kidney Injury" (2 trials), "COVID-19" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Acute Respiratory Failure" (1 trials). Many other conditions were trialed in "Centre Hospitalier Marc Jacquet" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier Marc Jacquet" are "Drug" (16 trials), "Other" (14 trials), "Procedure" (3 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "placebo" (2 trials), "2 post-mortem transcutaneous lung biopsies (1 anterior ; 1 posterior) using anatomical landmarks" (1 trials), "ABVD regimen" (1 trials) and "ATAZANAVIR" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier Marc Jacquet" are 39 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Centre Hospitalier Marc Jacquet". undefined are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Centre Hospitalier Marc Jacquet, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier Marc Jacquet, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 12 trials that are defined as “Not Applicable".